15-50481558-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_005154.5(USP8):c.1296A>G(p.Gln432Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00151 in 1,612,928 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0078 ( 24 hom., cov: 32)
Exomes 𝑓: 0.00086 ( 19 hom. )
Consequence
USP8
NM_005154.5 synonymous
NM_005154.5 synonymous
Scores
1
Clinical Significance
Conservation
PhyloP100: -0.559
Publications
15 publications found
Genes affected
USP8 (HGNC:12631): (ubiquitin specific peptidase 8) This gene encodes a protein that belongs to the ubiquitin-specific processing protease family of proteins. The encoded protein is thought to regulate the morphology of the endosome by ubiquitination of proteins on this organelle and is involved in cargo sorting and membrane trafficking at the early endosome stage. This protein is required for the cell to enter the S phase of the cell cycle and also functions as a positive regulator in the Hedgehog signaling pathway in development. Pseudogenes of this gene are present on chromosomes 2 and 6. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
USP8 Gene-Disease associations (from GenCC):
- autosomal recessive spastic paraplegia type 59Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary spastic paraplegiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 15-50481558-A-G is Benign according to our data. Variant chr15-50481558-A-G is described in ClinVar as [Benign]. Clinvar id is 528045.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.559 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0078 (1189/152366) while in subpopulation AFR AF = 0.0275 (1145/41580). AF 95% confidence interval is 0.0262. There are 24 homozygotes in GnomAd4. There are 559 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR,AD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP8 | NM_005154.5 | c.1296A>G | p.Gln432Gln | synonymous_variant | Exon 11 of 20 | ENST00000307179.9 | NP_005145.3 | |
USP8 | NM_001128610.3 | c.1296A>G | p.Gln432Gln | synonymous_variant | Exon 11 of 20 | NP_001122082.1 | ||
USP8 | NM_001283049.2 | c.1065A>G | p.Gln355Gln | synonymous_variant | Exon 9 of 17 | NP_001269978.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00778 AC: 1185AN: 152248Hom.: 24 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1185
AN:
152248
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000857 AC: 1251AN: 1460562Hom.: 19 Cov.: 31 AF XY: 0.000723 AC XY: 525AN XY: 726480 show subpopulations
GnomAD4 exome
AF:
AC:
1251
AN:
1460562
Hom.:
Cov.:
31
AF XY:
AC XY:
525
AN XY:
726480
show subpopulations
African (AFR)
AF:
AC:
1046
AN:
33410
American (AMR)
AF:
AC:
38
AN:
44442
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26108
East Asian (EAS)
AF:
AC:
0
AN:
39662
South Asian (SAS)
AF:
AC:
10
AN:
85722
European-Finnish (FIN)
AF:
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
AC:
5
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
37
AN:
1111694
Other (OTH)
AF:
AC:
115
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
69
138
206
275
344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00780 AC: 1189AN: 152366Hom.: 24 Cov.: 32 AF XY: 0.00750 AC XY: 559AN XY: 74516 show subpopulations
GnomAD4 genome
AF:
AC:
1189
AN:
152366
Hom.:
Cov.:
32
AF XY:
AC XY:
559
AN XY:
74516
show subpopulations
African (AFR)
AF:
AC:
1145
AN:
41580
American (AMR)
AF:
AC:
26
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5196
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10
AN:
68038
Other (OTH)
AF:
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
62
125
187
250
312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.